Artie Villasanta

Senior Reporter
The Latest
-
‘Abe 2.0’ Yoshihide Suga Expected To Continue With Abenomics
The strawberry farmer's son is seen as a successful political operator who gets things done. The strawberry farmer's son is seen as a successful political operator who gets things done. -
Democrats Probe Trump Officials Censoring CDC Reports
Another scandal involving the Trump administration has its appointees censoring bad news about the COVID-19 pandemic to help in Trump's re-election bid. Another scandal involving the Trump administration has its appointees censoring bad news about the COVID-19 pandemic to help in Trump's re-election bid. -
U.S. Expected To Maintain Military Edge Over China For Next 30 Years
The Pentagon assesses it has nothing to fear from the People's Liberation Army for the next three decades. The Pentagon assesses it has nothing to fear from the People's Liberation Army for the next three decades. -
Biden Leads Trump 49% To 39% Among Voters In Presidential Race
Joe Biden now leads president Donald Trump by 10 percentage points in the race for the White House. Joe Biden now leads president Donald Trump by 10 percentage points in the race for the White House. -
China Retaliates Vs Trump; Limits Travel Of U.S. Diplomats
China retaliates for the Trump administration's continuing series of moves to restrict the travel of its diplomats within the United States. China retaliates for the Trump administration's continuing series of moves to restrict the travel of its diplomats within the United States. -
Trump Earns $1.9 Billion From Businesses In 3 Years As U.S. President
Despite relinquishing control of his businesses to his family, Donald Trump still earned $1.9 billion in is three years as U.S. president. Despite relinquishing control of his businesses to his family, Donald Trump still earned $1.9 billion in is three years as U.S. president. -
World's 1st Nasal Spray COVID-19 Vaccine To Begin Phase 1 Trials In China
China's health authorities have approved Phase 1 clinical trials of the world's first intranasal candidate vaccine. China's health authorities have approved Phase 1 clinical trials of the world's first intranasal candidate vaccine. -
U.S. Air Force 'China Bomber' To Make First Flight In 2022
The incredible B-21 Raider strategic bomber of the U.S. Air Force capable of attacking China will see its first flight in 2022. The incredible B-21 Raider strategic bomber of the U.S. Air Force capable of attacking China will see its first flight in 2022. -
Japan, U.K. Agree To New Trade Deal
The United Kingdom and Japan have agreed to a new trade deal in princple that will remove 99% of tariffs between both countries. The United Kingdom and Japan have agreed to a new trade deal in princple that will remove 99% of tariffs between both countries. -
Two COVID-19 Vaccines Given To Hundreds Of Thousands Chinese
China has taken the contentious step of approving the use of two unproven COVID-19 vaccines on the general population. China has taken the contentious step of approving the use of two unproven COVID-19 vaccines on the general population.